Literature DB >> 2379782

Symptom development and prognosis in primary biliary cirrhosis: a study in two centers.

H C Mitchison1, M R Lucey, P J Kelly, J M Neuberger, R Williams, O F James.   

Abstract

The prognosis of patients with asymptomatic primary biliary cirrhosis has been uncertain. Cases of primary biliary cirrhosis in 95 patients from two centers are presented: 70 patients from a regional referral center (Freeman Hospital, FH) and 25 from an international tertiary referral center (King's College Hospital, KCH) with similar mean age at diagnosis and duration of follow-up (median, 12 months). During follow-up, 19 of 70 FH patients and 15 of 25 KCH patients developed symptoms (P less than 0.001); the mean time to symptom appearance was 43 months at FH and 35 months at KCH (P = 0.0012). Twenty-five of 95 patients died, 15 of 34 subjects who had developed symptoms (all liver-related deaths) and 10 of 61 who remained asymptomatic (all non-liver-related deaths) (P less than 0.001). Hepatic mortality was worse than among the normal population (P less than 0.05). A comparison of those patients developing symptoms with 111 at FH and 165 at KCH who presented with symptoms suggests no difference in survival once hepatic symptoms appear. In both centers, hepatic mortality was strongly related to symptom appearance in asymptomatic primary biliary cirrhosis: patients developing symptoms resemble those with symptoms at presentation. Other differences between the centers may reflect different referral patterns.

Entities:  

Mesh:

Year:  1990        PMID: 2379782     DOI: 10.1016/0016-5085(90)90968-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Autoantibodies as predictors of disease.

Authors:  D Leslie; P Lipsky; A L Notkins
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  The natural history of primary biliary cirrhosis.

Authors:  J L Boyer; W Shockcor; T C Mahl
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

3.  Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort.

Authors:  M I Prince; A Chetwynd; W L Craig; J V Metcalf; O F W James
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

4.  New directions in primary biliary cirrhosis.

Authors:  M C Bateson
Journal:  BMJ       Date:  1990-12-08

5.  Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis.

Authors:  C Rigamonti; L M Shand; M Feudjo; C C Bunn; C M Black; C P Denton; A K Burroughs
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

6.  Liver/spleen volume ratio as a predictor of prognosis in primary biliary cirrhosis.

Authors:  Yosuke Murata; Masanori Abe; Yoichi Hiasa; Nobuaki Azemoto; Teru Kumagi; Shinya Furukawa; Bunzo Matsuura; Kojiro Michitaka; Norio Horiike; Morikazu Onji
Journal:  J Gastroenterol       Date:  2008-08-17       Impact factor: 7.527

Review 7.  Primary biliary cirrhosis.

Authors:  J Neuberger; M Lombard; R Galbraith
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

8.  Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis.

Authors:  Runalia Bahar; Kimberly A Wong; Chung H Liu; Christopher L Bowlus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-03

9.  Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival.

Authors:  M C Bateson; P Gedling
Journal:  Postgrad Med J       Date:  1998-08       Impact factor: 2.401

10.  Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.

Authors:  Cristina Rigamonti; Dimitrios P Bogdanos; Maria G Mytilinaiou; Daniel S Smyk; Eirini I Rigopoulou; Andrew K Burroughs
Journal:  Int J Rheumatol       Date:  2011-12-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.